Comparsion of Coccydynia treatment with intractal manipulation concomitant to methyl prednisolone acetate injection & manipulation.
Phase 1
- Conditions
- Coccydynia.Sacrococcygeal Disorders not elsewhere classified Coccygodynia
- Registration Number
- IRCT138811203317N1
- Lead Sponsor
- Shiraz University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Presence of chronic (>2 months) Coccydynia, age between 18 and 70, no prior other treatments, consent to the study. Exclusion criteria: Presence of acute fracture of coccyx, Presence of osteoporosis, diabetes, or rheumatologic Disorders, known malignancy or congenital malformations.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Coccydynia treatment. Timepoint: One day, One week, One month & three months after the procedure. Method of measurement: Using a VAS and paris (functional Coccydinia impact) questionnaires.
- Secondary Outcome Measures
Name Time Method